Medindia

X

Biological E Reveals Results of Phase II/III Trials on JE Vaccine

by Kathy Jones on  September 19, 2011 at 6:55 PM Indian Health News   - G J E 4
Hyderabad based Biological E Limited has revealed that it has completed the Phase II and III trials of its inactivated Japanese Encephalitis (JE) vaccine on healthy kids aged between 1 to 3 years of age.
 Biological E Reveals Results of Phase II/III Trials on JE Vaccine
Biological E Reveals Results of Phase II/III Trials on JE Vaccine
Advertisement

The trials were conducted in eight different sites across the country and the company revealed that it will be submitted the results of the study to the Indian regulatory authority for licensure.

Advertisement
Commenting on the results of these trials, Dr. Vijay Kumar Datla, Chairman and Managing Director of Biological E. Limited said, "We are excited about the successful completion of our phase-II/III clinical study which enables us to offer this novel and safe vaccine to combat Japanese Encephalitis not only in India but also across Asia."

JE is one of the most common viral encephalitis that occurs in this part of the world. It is estimated that there are around 50,000 cases in Asia on an annual basis with resulting mortality rates ranging from 0.3% to 60%.

Source: Medindia
Advertisement

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
User Avatar
* Your comment can be maximum of 2500 characters
Notify me when reply is posted I agree to the terms and conditions

You May Also Like

Advertisement
View All

More News on: